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Abstract
Background: Obesity, typically quantified in terms of Body Mass Index (BMI) exceeding threshold values, is considered a
leading cause of premature death worldwide. For given body size (BMI), it is recognized that risk is also affected by body
shape, particularly as a marker of abdominal fat deposits. Waist circumference (WC) is used as a risk indicator supplementary
to BMI, but the high correlation of WC with BMI makes it hard to isolate the added value of WC.
Methods and Findings: We considered a USA population sample of 14,105 non-pregnant adults (age§18) from the National
Health and Nutrition Examination Survey (NHANES) 1999–2004 with follow-up for mortality averaging 5 yr (828 deaths). We
developed A Body Shape Index (ABSI) based on WC adjusted for height and weight:
ABSI:
WC
BMI2=3height1=2
:
ABSI had little correlation with height, weight, or BMI. Death rates increased approximately exponentially with above average
baseline ABSI (overall regression coefficient of z33% per standard deviation of ABSI [95% confidence interval: z20%–
z48%]), whereas elevated death rates were found for both high and low values of BMI and WC. 22% (8%–41%) of the
population mortality hazard was attributable to high ABSI, compared to 15% (3%–30%) for BMI and 15% (4%–29%) for WC.
The association of death rate with ABSI held even when adjusted for other known risk factors including smoking, diabetes,
blood pressure, and serum cholesterol. ABSI correlation with mortality hazard held across the range of age, sex, and BMI, and
for both white and black ethnicities (but not for Mexican ethnicity), and was not weakened by excluding deaths from the first 3
yr of follow-up.
Conclusions: Body shape, as measured by ABSI, appears to be a substantial risk factor for premature mortality in the general
population derivable from basic clinical measurements. ABSI expresses the excess risk from high WC in a convenient form
that is complementary to BMI and to other known risk factors.
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Introduction
According to the World Health Organization (WHO), over-
weight and obesity are increasing in prevalence and rank fifth as
worldwide causes of death among risk factors, behind high blood
pressure, tobacco use, high blood glucose, and physical inactivity.
In high and middle income countries, where the prevalence of
overweight and obesity among the adult population already
exceeds 50%, overweight and obesity occupy third place as risk
factors causing death, behind high blood pressure and tobacco use.
WHO defined overweight as body mass index (BMI; weight
divided by height2) at or above 25 kg m{2, with obesity defined as
BMI§30 kg m{2 [1]. Guidelines published by the USA National
Institutes of Health, using the same definition, considered that
overweight and obesity are the second leading cause of prevent-
able death in the USA, behind smoking [2].
These BMI-based obesity guidelines have been accompanied by
doubt as to the validity of BMI as an indicator of dangerous
obesity. BMI does not distinguish between muscle and fat
accumulation [3–6], and there is evidence that whereas higher
fat mass is associated with greater risk of premature death, higher
muscle mass reduces risk [7]. As well, BMI does not distinguish
between fat locations, when central or abdominal fat deposition is
thought to be particularly perilous [8–11]. Waist circumference
(WC) has emerged as a leading complement to BMI for indicating
obesity risk. A number of studies have found that WC predicted
mortality risk better than BMI [12–17]. A recent WHO report
summarized evidence for WC as an indicator of disease risk, and
suggests that WC could be used as a alternative to BMI [18].
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A key limitation, mentioned in the WHO report, of using WC
as a proxy for abdominal fat distribution is that it is sensitive to
body size (height and weight) as well as to fat percentage and
distribution. In fact, WC is highly correlated with BMI, to the
extent that differentiating the two as epidemiological risk factors
can be difficult [19]. According to a consensus statement on the
clinical usefulness of WC [20], ‘‘Further studies are needed to
establish WC cut points that can assess cardiometabolic risk, not
adequately captured by BMI and routine clinical assessments.’’
Scaling WC via allometric analysis to produce a quantity that is
independent of BMI offers one means of separating the impact on
health of body shape (degree of central bulge, presumably
correlating with abdominal fat deposits) from that of body size
(as measured by height, weight, and BMI). In this paper, our
objectives are (1) develop A Body Shape Index (ABSI) based on
WC that is approximately independent of height, weight, and
BMI; and (2) evaluate ABSI as a predictor of mortality across age,
sex, ethnicity, and BMI categories in a population sample,
compared to the conventional predictors BMI and WC.
Methods
Description of Data
We employed public-use releases of baseline interview and
medical examination and mortality outcome data from the
National Health and Nutrition Examination Survey (NHANES)
1999–2004. NHANES 1999–2004 was designed to sample the
civilian noninstitutionalized USA population using a cluster
approach. Mexicans and blacks, people 12–19 years of age and
60 years or older, low-income whites, and pregnant women were
oversampled to better understand the health status of these groups.
The survey included a home interview followed by a physical
examination at a mobile examination center. Mortality outcomes
based on the National Death Index were available through the end
of 2006, representing 2–8 years of follow-up. NHANES 1999–
2004 was approved by the National Center for Health Statistics
(NCHS) Research Ethics Review Board under Protocol #98–12,
and written informed consent was obtained from participants [21].
Basic demographic variables included baseline age (because of
privacy concerns, this was given as 85 for all those 85 or older),
sex, and ethnicity (given as Mexican, other Hispanic, white, black,
or other). Body measurements including height, weight, and waist
circumference were obtained by trained health technicians
following standardized procedures. Standing height was measured
using a digital stadiometer with a fixed vertical backboard and an
adjustable head piece. Weight in an examination gown was
measured on a digital scale. Waist circumference at the end of a
normal exhalation was measured to the nearest 0.1 cm with a steel
tape positioned just above the uppermost lateral border of the
ilium. All instruments were calibrated following uniform protocols.
These body measurements were generally not taken for people
confined to wheelchairs [22].
We considered adults (age§18) with height, weight, and waist
circumference measurements, excluding women determined to be
pregnant by self-report or urine pregnancy test. Of the 14,123
individuals meeting these criteria, 14,105 had valid mortality
follow-up data. The follow-up period for those remaining alive
averaged 4.8 yr, and there were 828 deaths.
Additional variables we considered were smoking status (coded
as yes if reported smoking cigarettes in last 5 days or smoking
‘every day’ or ‘some days’), diabetes status (coded yes if reported a
diabetes diagnosis or taking insulin or diabetes pills), and systolic
and diastolic blood pressure and serum total and HDL cholesterol
from the medical examination. A total of 12,044 individuals in our
sample had all these variables available, with 647 deaths during
follow-up.
We used the NHANES mobile examination center sample
weights, which adjust for targeted oversampling and nonresponse,
as well as information on which cluster each sampled individual
belonged to, following the analytic guidance provided by NCHS
[23]. Thus, the average ABSI values and risk estimates we
compute can be taken to hold for the wider nonpregnant adult
USA population insofar as NHANES was successful in sampling it.
Looking at the consistency of responses across subgroups within
the sample can also provide some guidance on the wider
applicability of our results.
Construction of the Body Shape Index
We performed linear least-squares regression on log (WC) as a
function of log (height) and log (weight) for the entire nonpreg-
nant adult sample. (Pregnant woman averaged bigger WC for a
given height and weight.) Expressing WC and height in m and
weight in kg, the results were.
log (WC)~({2:589+0:020)z(0:6807+0:0052) log (weight)
{(0:814+0:020) log (height)
ð1Þ
(R2~0:829), where the given uncertainties are standard errors.
Approximating the obtained regression coefficients with ratios of
small integers, we have,
WC!weight2=3height{5=6: ð2Þ
We defined A Body Shape Index (ABSI) to be proportional to
the ratio of actual WC to the WC expected from the regression
allometry:
ABSI:WC weight{2=3 height5=6~
WC
BMI2=3 height1=2
: ð3Þ
The sample mean and standard deviation of ABSI thus defined
is (0:0808+0:0053) m11=6 kg{2=3.
Correlation coefficients of ABSI with height, weight, BMI and
WC in the NHANES sample are shown in Table 1. It can be seen
that most variability in WC reflects variability in BMI (r&0:9) and
that unlike BMI, WC also has some correlation with height
(r&0:2), consistent with earlier findings [24–26]. On the other
Table 1. Correlations between body size and shape.
Height Weight BMI WC ABSI
Height 1 0.452 20.040 0.174 0.040
Weight 0.380 1 0.867 0.874 0.049
BMI 0.007 0.922 1 0.881 0.019
WC 0.163 0.908 0.918 1 0.439
ABSI 0.041 0.020 0.007 0.361 1
Correlation coefficients between height, weight, BMI, WC, and ABSI among
NHANES nonpregnant adults (n~14123). Right side (above diagonal) shows
correlations of the raw values; left side (below diagonal) shows correlations of
the z scores relative to age- and sex-specific means.
doi:10.1371/journal.pone.0039504.t001
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hand, ABSI shows little correlation with height, weight, or BMI
(DrDv0:1). Its correlation with WC is modest (r&0:4), since most
variability in WC is correlated with BMI and therefore excluded
from ABSI.
Conversion to z Scores
To control for age and sex differences in mean ABSI, we entered
it into proportional hazards regression for mortality as a z score:
ABSI z score~
ABSI{ABSImean
ABSISD
, ð4Þ
where the population ABSI mean and standard deviation depend
on age and sex. To estimate ABSImean and ABSISD, we first
computed the sample mean and standard deviation for each age,
separately for males and females and using the NHANES sample
weights (markers in Figure 1a-b). Then we smoothed the
ABSImean(age) and ABSI
2
SD(age) curves for each sex using
Tikhonov regularization with a regularization matrix that approx-
imates a second derivative operator and a regularization parameter
chosen so that the mean square residual between the curve and the
sample values, scaled by the estimated standard error of the sample
values, is equal to 1 [27]. These smoothed values (curves in Figure 1)
were used for converting ABSI to z scores following Eq. 4.
Individuals age 85 and over (for whom the exact age was not
available) were not included in the smoothing, and their ABSI
values were converted to z scores using the sample mean and
standard deviation (asterisks near right edges of panels in Figure 1).
The age and sex specific ABSImean and ABSISD used for
computing ABSI z scores are tabulated as (Table S1).
Mean ABSI increased steadily from midlife into old age
(Figure 1a). Mean ABSI was consistently higher in males than
females after young adulthood (Figure 1a), while the scatter in
ABSI at a given age was greater in females than in males
(Figure 1b). The age- and sex-specific BMI and WC means
(Figure 1c,e), calculated using the same approach, showed
different behavior than ABSI, falling after about age 60. Mean
WC was higher in males while mean BMI was higher in females,
consistent with the higher mean ABSI in males compared to
females. As with ABSI, variability in BMI and WC was higher in
females than in males (Figure 1d,f).
Mortality Hazard Modeling
To quantify the association of baseline ABSI with death rate, we
employed Cox proportional hazard modeling for mortality with
age as the time scale [28]. In this approach, log death rate is
modeled as a nonparametric function of age plus fitted coefficients
that multiply the values of predictors, such as baseline ABSI.
Predictors may be entered as continuous variables or discretized
into two or more categories (such as quantiles of ABSI), depending
on their nature and the desired model. ABSI and the other
anthropometric variables (BMI, WC) were entered as z scores
relative to age- and sex-specific normals, obtained as described
above, to avoid confounding by age and sex differences in body
size and shape.
Two types of models were employed. In one (‘unadjusted’), the
anthropometric variable of interest (ABSI, BMI, or WC) was the
only predictor entered. In the second (‘adjusted’), additional
predictors corresponding to other known major risk factors were
entered. Comparing the unadjusted and adjusted model coeffi-
cients showed to what extent the mortality risk associated with
higher ABSI, BMI, or WC changed when these other risk factors
are controlled for. The additional factors considered were sex,
ethnicity, smoking status, presence of diabetes, blood pressure, and
serum cholesterol. Sex, ethnicity, smoking status, and presence of
diabetes were all entered as binary variables. Ethnicity was entered
as 1 for blacks and 0 for all others, since we found that blacks had
significantly elevated death rates compared to the other four
ethnicities, whose death rates were not significantly different from
each other. Systolic and diastolic blood pressure and total and
HDL cholesterol levels were each entered as z scores relative to
age- and sex-specific normals, obtained as described for ABSI.
Because not all individuals with anthropometric measurements
also had the other data needed for the adjusted analysis, the
unadjusted analyses were run twice – once for the full sample with
available anthropometry (n~14105) and once restricted to the
sample used for the adjusted analysis (n~12044).
We also determined the mortality risk associated with ABSI,
BMI, and WC for subgroups of the NHANES sample, in order to
test the robustness and range of applicability of coefficients
determined for the entire sample. Subgroups included males and
females; people younger and older than 65 yr at baseline; the three
largest ethnic groupings (whites, blacks, and Mexicans); and people
with BMI above and below the age- and sex-specific mean. As
another check of whether these attributes impact the association
with mortality, we checked the significance in the proportional
hazard model of interaction terms of ABSI (BMI, WC) with sex,
age, ethnicity variables (white, black, or Mexican), and BMI. To
address the question of whether ABSI predicts medium-term as
compared to short-term mortality, we conducted an additional
analysis where the modeled follow-up period started 3 yr after the
baseline, thus excluding from consideration all deaths within 3 yr
of examination.
In Cox proportional hazard modeling, the relationship between
hazard (here, death rate) and continuous variables, such as ABSI
here, is most commonly estimated on the assumption that the
logarithm of the hazard is a linear function of the variable; this
yields a single regression coefficient that summarizes the strength
of the relationship between the variable and log hazard. A
recommended test of this linearity assumption is to fit an
alternative model where the dependence of log hazard on the
variable is described by a smoothing spline, with the degree of
smoothing determined to optimize the Akaike Information
Criterion [29,30]. Linearity is rejected if the nonlinear terms in
the fitted smoothing spline are different from zero with low p
value. Our testing showed that the linearity assumption did not
hold for ABSI, BMI or WC. In showing results from the models
described above, we retained the linearity assumption for all three
variables to facilitate comparing mortality hazards across popu-
lations and population subgroups. In separate analyses, we also fit
smoothing splines to the association with mortality risk of ABSI,
BMI, and WC in order to visualize it as accurately as possible. To
quantify in a simpler form the nonlinear relationship between
ABSI (BMI, WC) and log mortality, we also carried out analyses
where risk was computed separately for each quintile of the ABSI
(BMI, WC) z score, relative to the middle quintile.
A measure of the fraction of the total population mortality
hazard predicted by high values of ABSI (BMI, WC) was
calculated as.
Fraction population mortality hazard from high values
~
P
i,high fi(Ri{1)P
i,all fiRi
ð5Þ
where fi is the fraction of the population in each quantile and Ri is
the relative risk in each quantile. The quantiles we used for this
A Body Shape Index Predicts Mortality Hazard
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Figure 1. Mean and standard deviation of ABSI, BMI, andWC by age and sex.Markers show the sample quantities for each age; the smooth
curves shown were used to convert values to z scores. Units are m11=6 kg{2=3 for ABSI, kg m{2 for BMI, and m for WC.
doi:10.1371/journal.pone.0039504.g001
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calculation were the top 40%, middle 20%, and bottom 40%, with
the top 40% regarded as the ‘high’ range included in the
numerator, and risks were relative to the middle quintile.
Uncertainty in this expression was approximated as being due
only to uncertainty in the numerator Ri.
While converting variables to z scores before entering them into
a hazard regression model may be methodologically preferable
given the nonlinear effects of age and sex on mean ABSI, BMI,
and WC (Figure 1), we also conducted the same proportional
hazard modeling using the original variables, rather than z scores,
as predictors. For these analyses, sex was included as a predictor
even for the unadjusted models, in order to control for the sex
differences in ABSI, BMI, and WC distributions.
Proportional hazard modeling, including differential sample
weighting and adjustment for the cluster survey design, was carried
out using the survey package in the computer language R [31]. For
all analyses, pv0:05 (two-tailed) was taken as the threshold for
statistical significance. This corresponds to the 95% confidence
interval of the exponent of a linear regression log hazard
coefficient not including 1 (as would be the case under the null
hypothesis that the variable has no effect on the death rate).
Results
Higher Mortality Hazard for Increasing ABSI
Table 2 shows the impact of ABSI z score, as a continuous
variable, on death rate, along with results for BMI and WC
z scores. ABSI clearly has distinct impacts on mortality compared
to BMI and WC: if we model the relationship between the z scores
and log mortality risk as linear, the regression coefficients imply
that uniformly increasing the population ABSI by one standard
deviation would result in a significant increase of 33% (95%
confidence interval: z20%-z48%), while the corresponding
linear regression coefficients for BMI and WC are not significantly
different from zero. Because the proportional hazard regression
coefficients for ABSI, BMI, and WC showed little impact –
generally shifting by less than their standard error – from either
restricting the sample to those with data for the other risk factors
(sex, ethnicity, smoking, diabetes, blood pressure, and serum
cholesterol; middle column of Table 2) or from adjusting for the
other risk factors (right column of Table 2), we carried out the
analyses described below with unadjusted models.
Mortality Hazard from Increasing ABSI by Subgroup
Restricting our analysis to males or females within the sample
does not significantly change the impact of increasing ABSI on
mortality (Table 3); the change in mortality hazard per standard
deviation increase in ABSI is z32% (95% confidence interval:
z15%–z50%) for males and z35% (95% confidence interval:
z18%–z54%) for females. Further, high ABSI predicts similar
elevation of relative mortality hazard for younger (age v65 yr at
baseline) and older (age §65 yr) individuals, with narrower
confidence intervals for the older group because of their much
higher absolute death rate over the follow-up period (Table 3).
ABSI predicted mortality among individuals with above-mean
BMI about as well as it did for individuals with below-mean BMI
(Table 3). Among the three main ethnic groups in the sample,
ABSI predicted mortality in both whites and blacks, while ABSI
was not a significant predictor of mortality in Mexicans (Table 3).
These conclusions from subgroup analysis were largely borne
out by checking the significance of interaction terms added to the
Cox proportional hazard model. ABSIage, ABSIsex, and
ABSIBMI interactions were not significant, confirming that high
ABSI predicts mortality across these categories. By contrast, the
impact of increasing BMI and WC depended strongly on BMI
(Table 3), consistent with U-shaped relationships where lower
weight would increase mortality at low BMI and decrease it at
high BMI. Interaction with ABSI of an indicator variable for white
ethnicity were significantly positive, implying that whites with high
ABSI show greater relative risk elevation than other USA
ethnicities.
High ABSI continued to be a significant predictor of death even
when the first 3 yr of the follow-up period were excluded (Table 3),
suggesting that the correlation of higher ABSI with death rate is
not merely due to a propensity of acutely ill people to have high
ABSI.
Mortality Hazard by ABSI Quantile
To examine the correlation of different levels of ABSI with
death rate, we stratified the population into quintiles by ABSI z
score, where the middle (third) quintile included those near the
population mean ABSI, and conducted proportional hazard
modeling with ABSI quintiles, rather than ABSI z score, as the
predictor variables, with hazard ratios expressed relative to the
middle quintile. We found that people with low ABSI (first and
second quintiles) had nonsignificantly decreased mortality risk
relative to the middle quintile, while ABSI in the fourth and fifth
quintiles was associated with progressively and significantly
increased mortality risk (Table 4).
Similar analyses were conducted with BMI and WC quintiles.
BMI and WC in the first quintile were both associated with
significantly greater mortality hazard than for the middle quintile.
Significantly increased death rate compared to the middle quintile
was also seen for WC and BMI in the fifth quintile (Table 4).
Comparing the excess mortality hazard from high ABSI (top two
quintiles) with that posed by high BMI and WC as a fraction of the
total population death rate, we found that 22% (8%–41%) of the
population mortality hazard was attributable to high ABSI,
compared to 15% (3%–30%) for BMI and 15% (4%–29%) for
WC. Plotting estimated mortality risk by percentile from models
with ABSI, BMI, or WC as continuous predictor variables
(Figure 2), with smoothing splines used to represent their nonlinear
associations with mortality, gives results consistent with the
quantile analyses. While risk increases progressively with increas-
ing ABSI, BMI and WC risk is lowest near the population median
and increases for both high and low values.
Figure 3 shows the estimated relative mortality risk taking both
body size (BMI) and shape (ABSI) z score into account. These
estimates are based on the lack of interaction we found between
BMI and ABSI as predictors of mortality, so that the estimated
Table 2. Body size and shape z scores and mortality hazard.
Hazard ratio per SD increase
Unadjusted Restricted Adjusted
ABSI 1.33 (1.20–1.48) 1.37 (1.23–1.53) 1.30 (1.16–1.44)
BMI 0.98 (0.89–1.08) 0.98 (0.88–1.09) 0.96 (0.86–1.08)
WC 1.07 (0.98–1.16) 1.08 (0.98–1.20) 1.05 (0.94–1.17)
Results of Cox proportional hazard modeling for mortality risk with ABSI, BMI, or
WC z scores taken as linear predictors. Ranges in parentheses are 95%
confidence intervals. The restricted models are unadjusted but included only
those people who had all the measurements required for the adjusted model.
The adjusted models included as additional predictors sex, ethnicity, smoking,
presence of diabetes, blood pressure, and serum cholesterol.
SD = standard deviation.
doi:10.1371/journal.pone.0039504.t002
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mortality risk given both values is the product of that due to each
separately (Figure 2a, b). Lowest risk is found at below-average
ABSI and near average BMI (lower middle of plot), while risk
elevations of above 100% are found at high ABSI and BMI either
below or above average (upper left and upper right corners of
plot).
We found that our main results continued to hold when the
original variables, rather than their z scores, were used as mortality
predictors. Log mortality risk increased steadily with ABSI, while
decreasing for increasing BMI and WC up to values around the
population median (Figure 4). The association of ABSI with
mortality hazard remained after adjusting for other known risk
factors (Table 5).
Discussion
The newly developed and applied ABSI is based on WC, weight
and height, where high ABSI indicates that WC is higher than
expected for a given height and weight and corresponds to a more
central concentration of body volume. Applying ABSI along with
BMI as a predictor variable separates the influence of the
component of body shape measured by WC from that of body
size. Our finding that higher ABSI predicts mortality hazard is
thus quite analogous to the outcome of analyses which have
adjusted WC for BMI without invoking ABSI. Thus, an analysis of
mortality outcomes in an elderly (§65 yr) USA cohort found that
including both BMI and WC as continuous variables in a Cox
proportional hazard model for mortality results in a direct
correlation between WC and mortality and an inverse correlation
between BMI and mortality [12]. In a large multination European
cohort, stratifying by BMI category transformed the curve of
mortality risk as a function of WC from U-shaped to more linear,
similar to our curve of mortality risk as a function of ABSI quantile
[14]. Our work also follows on findings that dividing WC by
height increases its ability to predict cardiometabolic risk factors
[32–35]. Some conceptual advantages of introducing ABSI are
that it accounts for the sublinear increase of WC with BMI (i.e.
WC!BMI2=3) along with the nonlinear association of WC with
height, and that using it instead of WC avoids inflation of
regression uncertainty associated with the near collinearity of WC
and BMI.
In the USA population as sampled in NHANES, ABSI
predicted mortality risk across age, sex, and weight, although the
ethnic difference found suggests that analysis of more cohorts is
needed to delineate the limits of ABSI’s utility. A logical next step
would be to investigate the association of ABSI with longer-term
Table 3. Mortality hazard by subgroup.
Hazard ratio
Deaths/N ABSI BMI WC
All 828/14105 1.33 (1.20–1.48) 0.98 (0.89–1.08) 1.07 (0.98–1.16)
Male 502/7133 1.32 (1.15–1.50) 0.92 (0.81–1.06) 1.00 (0.88–1.14)
Female 326/6972 1.35 (1.18–1.54) 1.04 (0.91–1.19) 1.14 (1.01–1.30)
v65 yr 213/10728 1.37 (1.12–1.69) 1.05 (0.84–1.31) 1.12 (0.91–1.39)
§65 yr 615/3377 1.31 (1.18–1.45) 0.94 (0.87–1.02) 1.04 (0.96–1.12)
White 483/6709 1.43 (1.26–1.62) 1.02 (0.92–1.13) 1.12 (1.02–1.24)
Black 165/2882 1.21 (1.02–1.43) 0.68 (0.54–0.85) 0.76 (0.63–0.91)
Mexican 134/3392 1.11 (0.95–1.29) 0.78 (0.61–0.99) 0.84 (0.63–1.12)
High BMI 356/6011 1.37 (1.19–1.59) 1.20 (1.01–1.42) 1.39 (1.21–1.62)
Low BMI 472/8094 1.31 (1.12–1.51) 0.50 (0.40–0.62) 0.80 (0.64–1.00)
§3 yr follow up 408/11346 1.32 (1.15–1.52) 1.01 (0.90–1.14) 1.10 (1.00–1.22)
Interaction term p-values
female 0.81 0.24 0.17
age 0.93 0.28 0.58
white +, 0:005 0.11 0.052
black 0.21 2,v0:001 2,v0:001
mexican 0.07 0.16 0.16
bmi 0.36 +,v0:001 +,v0:001
Cox proportional hazard modeling for mortality hazard ratio per unit of ABSI, BMI or WC z score (standard deviation). Ranges in parentheses are 95% confidence
intervals. The sign of significant interaction terms is given. High BMI is defined as exceeding the age- and sex-specific population mean.
doi:10.1371/journal.pone.0039504.t003
Table 4. Mortality by quintile.
Hazard ratio
Quintile ABSI BMI WC
1 (lowest) 0.97 (0.69–1.37) 1.88 (1.44–2.45) 1.51 (1.12–2.03)
2 0.93 (0.64–1.35) 1.23 (0.89–1.69) 1.31 (0.92–1.87)
3 (reference) 1 1 1
4 1.46 (1.08–1.99) 1.37 (0.95–1.97) 1.30 (0.95–1.77)
5 (highest) 1.93 (1.39–2.68) 1.71 (1.22–2.39) 1.72 (1.28–2.32)
Cox proportional hazard modeling for mortality risk with ABSI, BMI or WC z
score quintiles taken as the predictors. Hazard ratios are relative to the middle
quintile in each case. Ranges in parentheses are 95% confidence intervals.
The between-quintile cut points are {0:868,{0:272,z0:229,z0:798 for ABSI;
{0:759,{0:337,z0:113,z0:746 for BMI; and{0:826,{0:346,z0:120,z0:775
for WC.
doi:10.1371/journal.pone.0039504.t004
A Body Shape Index Predicts Mortality Hazard
PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e39504
mortality risk, as well as its ability to predict morbidity and
impaired quality of life.
What aspect of human physiology measured by ABSI accounts
for its association with death rate? At a given height and weight,
high ABSI may correspond to a greater fraction of visceral
(abdominal) fat compared to peripheral tissue. As mentioned in the
Introduction, excess visceral fat has been associated with a variety
of potentially adverse metabolic changes. Equally important may
Figure 2. Mortality hazard by ABSI, BMI, and WC z score relative to age and sex specific normals. Estimates are from proportional hazard
modeling where log mortality hazard is a smoothing-spline function in ABSI, BMI, or WC. Dashed curves show 95% confidence intervals.
Corresponding population percentiles are given in the top axis; the range shown is the 1st through 99th percentiles. The vertical axis is logarithmic.
doi:10.1371/journal.pone.0039504.g002
Figure 3. Estimated mortality hazard (relative to the population mean) by combination of BMI and ABSI z score. The ranges of BMI
and ABSI shown correspond to the 1st through 99th percentiles. The contour interval is 0.25.
doi:10.1371/journal.pone.0039504.g003
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be that individuals with high ABSI have a smaller fraction of mass
as limb muscle; lean tissue mass and limb circumference have been
shown to have strong negative correlations with mortality risk
[7,36]. Dual energy X-ray absorptimetry body composition data
for most of the NHANES 1999–2004 sample is available [37,38]
and could be used to investigate ABSI’s associations with muscle,
fat and bone fraction by site. For example, we found that ABSI is
positively correlated to trunk fat mass as estimated from X-ray
scans (r~z0:45 between z score of trunk fat mass adjusted for
height and weight and ABSI z score) but negatively correlated with
limb lean mass (r~{0:26), consistent with the above hypotheses;
by contrast, WC has only weak associations with both trunk fat
and limb lean mass after these are adjusted for height and weight
(r~{0:04 for both), suggesting that it is a less consistent indicator
of changes in body shape and composition not reflected in height
and weight.
We found that both low and high BMI increased the mortality
hazard compared to near-median BMI (U-shaped curve for
mortality hazard vs. BMI and WC in Figure 2). In the studied
population, the hazard sustained by low BMI quantiles appears to
be at least as great than that sustained by corresponding high BMI
quantiles, consistent with the nonsignificantly negative linear
regression coefficient for mortality hazard on BMI z score
(Table 2). This substantial mortality hazard for low BMI held
even though few (292/14105 or 2.1%) of the study population
were in the WHO ‘underweight’ category of BMIv18:5 kg m{2.
The lowest mortality hazard was for the middle quintile of both
BMI and WC, although the population median was well in the
WHO ‘overweight’ or ‘pre-obese’ category [39]: the 40th-60th
percentile range for the sample was 25:6{28:4 kg m{2, with the
exact cutoffs for the middle quintile of BMI z score varying by age
and sex (Figure 1c; cf. Figure 4b). Similarly, the 40th-60th
percentile range of population WC was 94–101 cm for men and
88–97 cm for women, above most suggested cut-off points for
higher mortality hazard [18]. These results add to many previous
studies that show high population mortality hazard even in
developed countries from underweight compared to overweight,
particularly among the elderly and chronically ill [15,40–45],
supporting a rethinking of BMI-based obesity thresholds [46].
However, since high ABSI appears to identify increased mortality
risk independent of BMI, it could complement either low or high
BMI in risk assessment, as illustrated in Figure 3.
In addition to WC, inverse hip circumference, or waist to hip
ratio, have been suggested as alternative measures of body shape
that predict mortality better than BMI [18,47]. It is theorized that
gluteofemoral fat may benefit health by removing free fatty acids
from the bloodstream [48]. Different studies have reached a range
of conclusions about whether WC [14,16] or waist to hip ratio
[13,17] is a better predictor of mortality; a meta-analysis of British
studies found them to be equally good predictors [49]. A recent
prospective analysis from Mauritius found that higher WC and
lower hip circumference both correlated with greater mortality
risk, while BMI did not correlate with mortality risk [50]. An
analysis of an earlier NHANES cohort (NHANES III, examined
1988–1994) found that neither low nor high waist to hip ratio
significantly affected mortality hazard compared to an intermedi-
ate reference level, where levels were defined by analogy with
Figure 4. Mortality hazard by ABSI, BMI, and WC. Estimates are from proportional hazard modeling where log mortality hazard is a smoothing-
spline function in ABSI, BMI, or WC. Dashed curves show 95% confidence intervals. Corresponding population percentiles are given in the top axis;
the range shown is the 1st through 99th percentiles. The vertical axis is logarithmic. This is the same as Figure 2, but with ABSI, BMI, or WC, rather
than their z scores, used as predictors. Units are m11=6 kg{2=3 for ABSI, kg m{2 for BMI, and m for WC.
doi:10.1371/journal.pone.0039504.g004
Table 5. Body size and shape and mortality hazard.
Hazard ratio per SD increase
Unadjusted Restricted Adjusted
ABSI 1.39 (1.23–1.57) 1.44 (1.26–1.63) 1.34 (1.18–1.51)
BMI 1.00 (0.88–1.13) 0.99 (0.87–1.13) 0.97 (0.84–1.12)
WC 1.08 (0.97–1.21) 1.10 (0.97–1.25) 1.06 (0.93–1.22)
Results of Cox proportional hazard modeling for mortality risk with ABSI, BMI, or
WC, as well as sex, taken as linear predictors. Ranges in parentheses are 95%
confidence intervals. The restricted models are unadjusted but included only
those people who had all the measurements required for the adjusted model.
The adjusted models included as additional predictors ethnicity, smoking,
presence of diabetes, blood pressure, and serum cholesterol.
This is the same as Table 2, but with ABSI, BMI, or WC, rather than their z scores,
used as predictors.
SD = standard deviation. The population standard deviations used here are
0:00535 m11=6 kg{2=3 for ABSI, 6:20 kg m{2 for BMI, and 0:155 m for WC.
doi:10.1371/journal.pone.0039504.t005
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WHO obesity categories [41]. That study also found that waist to
hip ratio, despite its nondimensional form, was significantly
correlated to BMI (r&0:4{0:5), and we may hypothesize that
adjusting hip circumferences or waist to hip ratios for height and
weight, as done here for WC, would make them more useful as
predictors of mortality hazard. The significance of hip circumfer-
ence or waist to hip ratio cannot be evaluated with NHANES
1999–2004 data because hip circumference was not measured,
though it is possible that adjusting WC for height and weight may
indirectly provide similar information to waist to hip ratio – i.e. a
wider waist for given height and weight may imply narrower hips,
and vice versa. It would be of interest to compare the waist to hip
ratio’s performance with that of ABSI in suitable data sets, and it
may well be that ABSI can be improved as an indicator of
hazardous body shape by including hip circumference in addition
to height, weight and WC (which is why ABSI for now bears the
indefinite article).
This prospective study does not directly address whether
interventions aimed at reducing ABSI would reduce mortality
risk, independent of weight change, for which large randomized
controlled trials would be necessary. If ABSI does reflect malleable
body shape and composition attributes, however, we may
speculate that the effectiveness of weight loss interventions in
improving health outcomes would be affected by how they impact
WC relative to weight, since ABSI varies with the ratio
WC
BMI2=3
.
Lifestyle change that reduces ABSI, such as an exercise program
that builds skeletal muscle, may yield health benefits independent
of the amount of weight loss; indeed, exercise has been shown to
have beneficial health impacts for obese individuals, including
reductions in WC (and hence ABSI), even when weight loss does
not occur [51]. Weight loss programs including either low-calorie
diets or exercise can also reduce WC, along with BMI, enough to
reduce ABSI [52,53]. As other possible applications, the strong
association of ABSI with mortality may be of interest to actuaries
[54], and may be used as a selection criterion for enrollment in
clinical trials desired to have higher power to detect mortality
outcome differences with given sample size. Note that since ABSI
varies over a small range (population standard deviation is of order
5%, Figure 1b), it is sensitive to the accuracy of the biometric
measurements on which it is based. In particular, WC should be
measured according to the NHANES protocol [22] in order to
meaningfully compare ABSI with the population normals given
here, even though in general the association of WC with health
outcomes seems independent of the specified measurement
protocol [55].
In summary, body shape, as measured by ABSI, appears to be a
substantial risk factor for premature mortality in the general
population derivable from basic clinical measurements. ABSI
expresses the excess risk from high WC in a convenient form that
is complementary to BMI and to other known risk factors.
Supporting Information
Table S1 This table contains the mean and standard
deviation of ABSI by age and sex for NHANES 1999–2004,
based on all individuals with available data (except
pregnant women) and weighted to represent the larger
USA population which NHANES was intended to sample.
The smoothed means and standard deviations shown were used to
generate ABSI z scores. The table contains 11 space-separated
columns in plain text. The layout is: Column 1: Age (85 includes
those older than 85). Column 2: Number of males with available
data at this age. Column 3: ABSI mean for males at the given age.
Column 4: ABSI standard deviation for males at the given age.
Column 5: Smoothed ABSI mean for males at the given age.
Column 6: Smoothed ABSI standard deviation for males at the
given age. Columns 7–11: Same as columns 2–6, but for females.
(TXT)
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